share_log

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $50

Benzinga ·  Aug 7, 2023 06:22

HC Wainwright & Co. analyst Robert Burns maintains Replimune Group (NASDAQ:REPL) with a Buy and lowers the price target from $51 to $50.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment